Daniel Lynch is Director at bluebird bio, Inc. (BLUE). They have made 24 open-market trades across 2 companies since 2015, most recently 2025-07-01.
CIK 0001177082
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 24 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SWTX | SELL · 10b5-1 | 2025-02-20 | 2025-02-24 | $60.22 | $5.7M | -8.3% | -16.9% | -17.0% |
| SWTX | SELL · 10b5-1 | 2025-02-14 | 2025-02-19 | $60.00 | $24K | -14.1% | -19.5% | -25.3% |
| SWTX | SELL · 10b5-1 | 2025-02-10 | 2025-02-12 | $54.22 | $15.4M | -7.4% | -12.4% | -20.8% |
| BPMC | SELL | 2018-02-14 | 2018-02-16 | $80.42 | $1.0M | +12.1% | +24.9% | +2.0% |
| BPMC | SELL | 2018-02-12 | 2018-02-14 | $74.84 | $2.6M | +6.7% | +19.5% | -2.8% |
| BPMC | SELL | 2017-11-15 | 2017-11-17 | $63.57 | $420K | +13.8% | +11.0% | +25.1% |
| BPMC | SELL | 2017-09-18 | 2017-09-20 | $60.00 | $150K | +12.1% | +5.4% | +17.5% |
| BLUE | SELL | 2017-08-31 | 2017-09-05 | $120.00 | $60K | +4.0% | -0.4% | +28.3% |
| BPMC | SELL | 2017-07-05 | 2017-07-07 | $55.06 | $413K | -0.3% | -7.5% | +25.1% |
| BPMC | SELL | 2017-06-28 | 2017-06-30 | $50.28 | $3.3M | +3.9% | +2.6% | +34.2% |
| BLUE | SELL | 2017-06-23 | 2017-06-27 | $109.09 | $436K | -10.6% | -8.8% | +24.1% |
| BLUE | SELL | 2017-06-20 | 2017-06-22 | $120.03 | $300K | -4.7% | -9.5% | +18.5% |
| BLUE | SELL | 2017-06-08 | 2017-06-12 | $110.20 | $276K | +7.7% | -13.0% | +15.4% |
| BLUE | SELL | 2017-06-06 | 2017-06-08 | $100.14 | $453K | +2.7% | -14.5% | +15.0% |
| BLUE | SELL | 2017-06-05 | 2017-06-07 | $90.00 | $90K | +1.9% | -9.7% | +13.5% |
| BLUE | SELL | 2017-05-25 | 2017-05-30 | $80.00 | $80K | +42.1% | +37.5% | +35.0% |
| BLUE | SELL | 2017-04-27 | 2017-05-01 | $90.01 | $90K | -4.2% | -17.2% | +3.6% |
| BLUE | SELL | 2017-04-25 | 2017-04-27 | $86.75 | $174K | -0.9% | -13.1% | +10.8% |
| BLUE | SELL | 2017-03-24 | 2017-03-28 | $88.07 | $291K | -4.6% | -2.8% | +21.2% |
| BLUE | SELL | 2017-03-24 | 2017-03-28 | $87.10 | $148K | -4.6% | -2.8% | +21.2% |
| BLUE | SELL · 10b5-1 | 2017-03-16 | 2017-03-20 | $100.07 | $24K | -0.5% | -8.9% | +22.2% |
| BPMC | SELL | 2017-03-14 | 2017-03-16 | $40.12 | $301K | +5.0% | +14.3% | -3.7% |
| BLUE | SELL | 2017-03-01 | 2017-03-03 | $90.32 | $181K | +15.4% | +4.4% | -6.6% |
| BLUE | SELL | 2017-02-24 | 2017-02-28 | $78.69 | $157K | -0.7% | +2.9% | -12.5% |
| BLUE | SELL · 10b5-1 | 2017-02-15 | 2017-02-17 | $80.22 | $12K | +12.0% | +17.8% | +13.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.